TLR3 and colorectal carcinoma: Our findings show that activation of immune-related genes, such as interferon, which are known to belong to the antiviral pathway in CRC organoids, results in TLR3 activation in cancer cells in response to chemotherapy, highlighting the role of the TME in this innate immune response [55].